Science Explorer Interactive view Map
Company · Kiel · Germany

GALENpharma (Germany)

galenpharma.de/startseiteROR OpenAlex
Research works
2
fractional, all time
Citations
204
95.8 per fractional work
Top-10% rate
53.1%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: GALENpharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does GALENpharma (Germany) publish most on?

By volume: Galectins and Cancer Biology, Macrophage Migration Inhibitory Factor, Free Radicals and Antioxidants and Redox biology and oxidative stress.

Galectins and Cancer Bio…0Galectins and Cancer Biology: 0 fractional worksMacrophage Migration Inhibitory Factor: 0 fractional worksFree Radicals and Antioxidants: 0 fractional worksRedox biology and oxidat…0Redox biology and oxidative stress: 0 fractional worksElectron Spin Resonance …0Electron Spin Resonance Studies: 0 fractional worksStudies on Chitinases and Chitosanases: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksSignaling Pathways in Disease: 0 fractional worksIL-33, ST2, and ILC Pathways: 0 fractional works
ImmunologyOrganic ChemistryMolecular BiologyBiophysics

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Galectins and Cancer Biology Immunology 0 works
  2. 2 Macrophage Migration Inhibitory Factor Immunology 0 works
  3. 3 Free Radicals and Antioxidants Organic Chemistry 0 works
  4. 4 Redox biology and oxidative stress Molecular Biology 0 works
  5. 5 Electron Spin Resonance Studies Biophysics 0 works
  6. 6 Studies on Chitinases and Chitosanases Molecular Biology 0 works
  7. 7 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  8. 8 Signaling Pathways in Disease Molecular Biology 0 works
  9. 9 IL-33, ST2, and ILC Pathways Immunology 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.8%not open56.2%

World: 28% of research is openly available.

with international co-authors53.2%domestic only46.8%

World: 19% is written across borders.

How has GALENpharma (Germany)'s research output changed?

200520102015

Other research institutions in Kiel

All research institutions in Kiel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.